AmCad BioMed Corporation

Company Profile

Sector

Healthcare

Industry

Medical Devices

Employees

N/A

Website

www.amcad.com.tw

Country

Taiwan

Exchange

Taipei Exchange

AmCad BioMed develops computer-aided detection and diagnosis (CAD) software devices primarily in Taiwan. It offers products for early detection and diagnosis of various diseases.

The company's products include AmCAD-UT Detection, a CAD device for ultrasound images of thyroid nodules; and AmCAD-UO for detection of obstructive sleep apnea on awake patients. It also developing AmCAD-US, a software device for visualizing and quantifying statistical distributions of backscattered signals echoed by tissue compositions in the body from FDA-cleared ultrasound systems AmCAD-UB, an AI Solution for Breast Lesion Detection. The company was incorporated in 2008 and is based in Taipei City, Taiwan.

Key Stats

52-Week Range

NT$9.50NT$17.20

Beta0.29

Trailing P/EN/A

Forward P/EN/A

Trailing EPS-0.88

Avg Volume

Earnings & Analyst

Next EarningsN/A

EPS EstimateN/A

Target Mean PriceN/A

RecommendationNone

Recommendation MeanN/A

Recent SEC Filings

SEC filings for this ticker are not available yet.